Biography and Research Information
OverviewAI-generated summary
Saki Fukuda's research focuses on the pharmacological characterization of substances, including opioid analgesics and their analogs, and their effects in animal models. Fukuda has investigated automated methods for quantifying opioid withdrawal symptoms in neonatal rat pups and explored the potential of medium-chain triglycerides to induce antidepressant effects in animal models by influencing beta-hydroxybutyrate levels. Additionally, Fukuda's work includes examining the impact of deuterated buprenorphine on mitigating fentanyl effects in pregnant rats. Fukuda has published nine papers, accumulating 81 citations, and holds an h-index of 3. Key collaborators at the University of Arkansas for Medical Sciences include Lisa K. Brents, William E. Fantegrossi, Kyle Urquhart, and Michael D. Berquist.
Metrics
- h-index: 4
- Publications: 9
- Citations: 88
Selected Publications
-
In vitro and in vivo pharmacological characterization of fentanyl analogs (2025)
-
Automated quantification of opioid withdrawal in neonatal rat pups using Ethovision® XT software (2021)
Collaboration Network
Top Collaborators
- Automated quantification of opioid withdrawal in neonatal rat pups using Ethovision® XT software
- Deuterated Buprenorphine Mitigates Fentanyl Effects in Pregnant Rats
- Automated quantification of opioid withdrawal in neonatal rat pups using Ethovision® XT software
- Deuterated Buprenorphine Mitigates Fentanyl Effects in Pregnant Rats
- Deuterated Buprenorphine Mitigates Fentanyl Effects in Pregnant Rats
- Deuterated Buprenorphine Mitigates Fentanyl Effects in Pregnant Rats
- Medium-Chain Triglyceride Administration Induces Antidepressant Effects in Animal Models by Increasing Beta-Hydroxybutyrate Levels
- Medium-Chain Triglyceride Administration Induces Antidepressant Effects in Animal Models by Increasing Beta-Hydroxybutyrate Levels
- Medium-Chain Triglyceride Administration Induces Antidepressant Effects in Animal Models by Increasing Beta-Hydroxybutyrate Levels
- Medium-Chain Triglyceride Administration Induces Antidepressant Effects in Animal Models by Increasing Beta-Hydroxybutyrate Levels
- Medium-Chain Triglyceride Administration Induces Antidepressant Effects in Animal Models by Increasing Beta-Hydroxybutyrate Levels
- Medium-Chain Triglyceride Administration Induces Antidepressant Effects in Animal Models by Increasing Beta-Hydroxybutyrate Levels
- Medium-Chain Triglyceride Administration Induces Antidepressant Effects in Animal Models by Increasing Beta-Hydroxybutyrate Levels
- Medium-Chain Triglyceride Administration Induces Antidepressant Effects in Animal Models by Increasing Beta-Hydroxybutyrate Levels
- Medium-Chain Triglyceride Administration Induces Antidepressant Effects in Animal Models by Increasing Beta-Hydroxybutyrate Levels
- Medium-Chain Triglyceride Administration Induces Antidepressant Effects in Animal Models by Increasing Beta-Hydroxybutyrate Levels
Similar Researchers
Based on overlapping research topics